Robert Chess, Director at NEKTAR THERAPEUTICS (NKTR), sold 9,245 shares at $16.81 ($155K) on 2021-07-21, disclosed to the SEC on 2021-07-22.
Open-market sale of $155k NKTR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.80 | 2,106 | $35K | 22.8% |
| 2 | $16.81 | 3,524 | $59K | 38.1% |
| 3 | $16.81 | 3,524 | $59K | 38.1% |
| 4 | $16.80 | 91 | $2K | 1.0% |
| Total | $16.81 avg | 9,245 | $155K | 100% |
| Filing → |
| TWST | SELL | 2026-02-18 | $105K | — | Filing → |
| TWST | SELL | 2025-02-11 | $312K | — | Filing → |
| TWST | SELL | 2025-01-10 | $250K | — | Filing → |